You are here


A Quick and Easy Strategy for Cerebral Organoid Production

Researchers describe a new quick and easy method to produce “mini” brains, or cerebral organoids, which may aid the construction of new therapeutic treatment strategies

Big Consequences of a Little Carry-over in Mitochondrial Replacement Therapy

A new study suggests that while mitochondrial replacement therapy may be successful in the treatment of mitochondrial disease, small amounts of mitochondrial carry-over can allow disease reappearance

iPSC-Derived Retinal Ganglion Cells: A New Tool in the Battle Against Optic Neuropathies

A new study describing the differentiation of retinal ganglion cells from human pluripotent stem cells may provide a new tool to study optic neuropathies

iPSC-Reprogramming Keeps it Nice and Splice-y!

New research highlights the importance of alternative splicing at various stages of iPSC reprogramming

Correlation of Age and Mitochondrial Mutations in iPSCs

Research suggests that iPSCs generated from older patient samples are more likely to carry higher levels of mitochondrial DNA damage which could affect their therapeutic application

Microchamber, Mega mESC Pluripotency!

Researchers successfully apply a microchamber culture strategy for mESCs which potentiates endogenous signaling to promote pluripotency

Tackling Loss of Hearing with Mutation Correction of Patient Specific Stem Cells

Using patient specific induced pluripotent stem cells, a new study shows that cell-based treatments for deafness may be a future possibility

Mimicking Ocular Development and Treating Corneal Blindness using iPSCs

Researchers describe how multilayered ocular structures generated from iPSCs may provide a patient-specific means to treat forms of blindness

Boosting Vascular Therapies by Modulating the Microenvironment?

A Stem Cells study shows that modulating a microenvironmental factor can alter smooth muscle cell differentiation from ESCs; knowledge which could boost vascular therapies.

A Safe and Effective Means to Produce and Transplant iPSC-Derived Progenitors?

New research in SCTM describes a safe and effective new strategy for the treatment of type 1 diabetes using induced pluripotent stem cell-derived progenitors


Subscribe to RSS - ESCs/iPSCs